| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.05 |